{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T06:46:47Z","timestamp":1790750807859,"version":"4.1.0"},"reference-count":31,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","license":[{"start":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T00:00:00Z","timestamp":1648598400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n            <jats:title>OBJECTIVE:<\/jats:title>\n            <jats:p>Despite its heterogeneous phenotypes, sepsis or life-threatening dysfunction in response to infection is often treated empirically. Identifying patient subgroups with unique pathophysiology and treatment response is critical to the advancement of sepsis care. However, phenotyping methods and results are as heterogeneous as the disease itself. This scoping review evaluates the prognostic capabilities and treatment implications of adult sepsis and septic shock phenotyping methods.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>DATA SOURCES:<\/jats:title>\n            <jats:p>Medline and Embase.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>STUDY SELECTION:<\/jats:title>\n            <jats:p>We included clinical studies that described sepsis or septic shock and used any clustering method to identify sepsis phenotypes. We excluded conference abstracts, literature reviews, comments, letters to the editor, and in vitro studies. We assessed study quality using a validated risk of bias tool for observational cohort and cross-sectional studies.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>DATA EXTRACTION:<\/jats:title>\n            <jats:p>We extracted population, methodology, validation, and phenotyping characteristics from 17 studies.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>DATA SYNTHESIS:<\/jats:title>\n            <jats:p>Sepsis phenotyping methods most frequently grouped patients based on the degree of inflammatory response and coagulopathy using clinical, nongenomic variables. Five articles clustered patients based on genomic or transcriptomic data. Seven articles generated patient subgroups with differential response to sepsis treatments. Cluster clinical characteristics and their associations with mortality and treatment response were heterogeneous across studies, and validity was evaluated in nine of 17 articles, hindering pooled analysis of results and derivation of universal truths regarding sepsis phenotypes, their prognostic capabilities, and their associations with treatment response.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>CONCLUSIONS:<\/jats:title>\n            <jats:p>Sepsis phenotyping methods can identify high-risk patients and those with high probability of responding well to targeted treatments. Research quality was fair, but achieving generalizability and clinical impact of sepsis phenotyping will require external validation and direct comparison with alternative approaches.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/cce.0000000000000672","type":"journal-article","created":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T20:00:34Z","timestamp":1648670434000},"page":"e0672","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":22,"title":["Methods for Phenotyping Adult Patients in Sepsis and Septic Shock: A Scoping Review"],"prefix":"10.1097","volume":"4","author":[{"given":"Han","family":"Li","sequence":"first","affiliation":[{"name":"Division of Nephrology, Hypertension, and Renal Transplantation, Department of Medicine, University of Florida College of Medicine, Gainesville, FL."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asena","family":"Markal","sequence":"additional","affiliation":[{"name":"University of Florida College of Medicine, Gainesville, FL."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy A.","family":"Balch","sequence":"additional","affiliation":[{"name":"Department of Surgery, University of Florida College of Medicine, Gainesville, FL."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tyler J.","family":"Loftus","sequence":"additional","affiliation":[{"name":"Department of Surgery, University of Florida College of Medicine, Gainesville, FL."},{"name":"Precision and Intelligent Systems in Medicine (Prisma), University of Florida, Gainesville, FL."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip A.","family":"Efron","sequence":"additional","affiliation":[{"name":"Department of Surgery, University of Florida College of Medicine, Gainesville, FL."},{"name":"Sepsis and Critical Illness Research Center, University of Florida, Gainesville, FL."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tezcan","family":"Ozrazgat-Baslanti","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Hypertension, and Renal Transplantation, Department of Medicine, University of Florida College of Medicine, Gainesville, FL."},{"name":"Precision and Intelligent Systems in Medicine (Prisma), University of Florida, Gainesville, FL."},{"name":"Sepsis and Critical Illness Research Center, University of Florida, Gainesville, FL."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azra","family":"Bihorac","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Hypertension, and Renal Transplantation, Department of Medicine, University of Florida College of Medicine, Gainesville, FL."},{"name":"Precision and Intelligent Systems in Medicine (Prisma), University of Florida, Gainesville, FL."},{"name":"Sepsis and Critical Illness Research Center, University of Florida, Gainesville, FL."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,3,30]]},"reference":[{"key":"R1-20240807","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1001\/jama.2017.17687","article-title":"Enhancing recovery from sepsis: A review.","volume":"319","author":"Prescott","year":"2018","journal-title":"JAMA"},{"key":"R2-20240807","doi-asserted-by":"crossref","first-page":"e187571","DOI":"10.1001\/jamanetworkopen.2018.7571","article-title":"Prevalence, underlying causes, and preventability of sepsis-associated mortality in US acute care hospitals.","volume":"2","author":"Rhee","year":"2019","journal-title":"JAMA Netw Open"},{"key":"R3-20240807","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jama.2016.0287","article-title":"The third international consensus definitions for sepsis and septic shock (Sepsis-3).","volume":"315","author":"Singer","year":"2016","journal-title":"JAMA"},{"key":"R4-20240807","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/nri.2017.36","article-title":"The immunopathology of sepsis and potential therapeutic targets.","volume":"17","author":"van der Poll","year":"2017","journal-title":"Nat Rev Immunol"},{"key":"R5-20240807","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1164\/rccm.200903-0363OC","article-title":"Granulocyte-macrophage colony-stimulating factor to reverse sepsis-associated immunosuppression: A double-blind, randomized, placebo-controlled multicenter trial.","volume":"180","author":"Meisel","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"R6-20240807","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1007\/s00134-018-5143-7","article-title":"Efficacy and safety of trimodulin, a novel polyclonal antibody preparation, in patients with severe community-acquired pneumonia: A randomized, placebo-controlled, double-blind, multicenter, phase II trial (CIGMA study).","volume":"44","author":"Welte","year":"2018","journal-title":"Intensive Care Med"},{"key":"R7-20240807","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1001\/jama.286.15.1869","article-title":"Caring for the critically ill patient. High-dose antithrombin III in severe sepsis: A randomized controlled trial.","volume":"286","author":"Warren","year":"2001","journal-title":"JAMA"},{"key":"R8-20240807","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1164\/rccm.201007-1167OC","article-title":"Recombinant tissue factor pathway inhibitor in severe community-acquired pneumonia: A randomized trial.","volume":"183","author":"Wunderink","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"R9-20240807","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1097\/01.CCM.0000145229.59014.6C","article-title":"Efficacy and safety of the monoclonal anti-tumor necrosis factor antibody F(ab\u2019)2 fragment afelimomab in patients with severe sepsis and elevated interleukin-6 levels.","volume":"32","author":"Panacek","year":"2004","journal-title":"Crit Care Med"},{"key":"R10-20240807","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1097\/CCM.0000000000001402","article-title":"Interleukin-1 receptor blockade is associated with reduced mortality in sepsis patients with features of macrophage activation syndrome: Reanalysis of a prior phase III trial.","volume":"44","author":"Shakoory","year":"2016","journal-title":"Crit Care Med"},{"key":"R11-20240807","doi-asserted-by":"crossref","first-page":"e10128","DOI":"10.15252\/emmm.201810128","article-title":"Sepsis therapies: Learning from 30 years of failure of translational research to propose new leads.","volume":"12","author":"Cavaillon","year":"2020","journal-title":"EMBO Mol Med"},{"key":"R12-20240807","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1007\/s00134-019-05596-z","article-title":"Cardiovascular clusters in septic shock combining clinical and echocardiographic parameters: A post hoc analysis.","volume":"45","author":"Geri","year":"2019","journal-title":"Intensive Care Med"},{"key":"R13-20240807","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1001\/jama.2019.5791","article-title":"Derivation, validation, and potential treatment implications of novel clinical phenotypes for sepsis.","volume":"321","author":"Seymour","year":"2019","journal-title":"JAMA"},{"key":"R15-20240807","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1097\/CCM.0000000000004610","article-title":"Temperature trajectory subphenotypes correlate with immune responses in patients with sepsis.","volume":"48","author":"Bhavani","year":"2020","journal-title":"Crit Care Med"},{"key":"R16-20240807","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s12911-021-01460-7","article-title":"Unsupervised phenotyping of sepsis using nonnegative matrix factorization of temporal trends from a multivariate panel of physiological measurements.","volume":"21","author":"Ding","year":"2021","journal-title":"BMC Med Inform Decis Mak"},{"key":"R17-20240807","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.jcrc.2018.06.012","article-title":"Six subphenotypes in septic shock: Latent class analysis of the PROWESS shock study.","volume":"47","author":"G\u00e5rdlund","year":"2018","journal-title":"J Crit Care"},{"key":"R18-20240807","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1097\/CCM.0000000000005054","article-title":"Identifying high-risk subphenotypes and associated harms from delayed antibiotic orders and delivery.","volume":"49","author":"Han","year":"2021","journal-title":"Crit Care Med"},{"key":"R19-20240807","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/s13054-021-03541-5","article-title":"Coagulation phenotypes in sepsis and effects of recombinant human thrombomodulin: An analysis of three multicentre observational studies.","volume":"25","author":"Kudo","year":"2021","journal-title":"Crit Care"},{"key":"R20-20240807","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/S2213-2600(17)30294-1","article-title":"Classification of patients with sepsis according to blood genomic endotype: A prospective cohort study.","volume":"5","author":"Scicluna","year":"2017","journal-title":"Lancet Respir Med"},{"key":"R21-20240807","doi-asserted-by":"crossref","first-page":"104182","DOI":"10.1016\/j.compbiomed.2020.104182","article-title":"Identifying subpopulations of septic patients: A temporal data-driven approach.","volume":"130","author":"Sharafoddini","year":"2021","journal-title":"Comput Biol Med"},{"key":"R22-20240807","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1164\/rccm.201807-1419OC","article-title":"Transcriptomic signatures in sepsis and a differential response to steroids. From the VANISH randomized trial.","volume":"199","author":"Antcliffe","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"R23-20240807","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1164\/rccm.201806-1197OC","article-title":"Identifying novel sepsis subphenotypes using temperature trajectories.","volume":"200","author":"Bhavani","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"R24-20240807","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S2213-2600(16)00046-1","article-title":"Genomic landscape of the individual host response and outcomes in sepsis: A prospective cohort study.","volume":"4","author":"Davenport","year":"2016","journal-title":"Lancet Respir Med"},{"key":"R25-20240807","doi-asserted-by":"crossref","first-page":"e58142","DOI":"10.7554\/eLife.58142","article-title":"Spectral clustering of risk score trajectories stratifies sepsis patients by clinical outcome and interventions received.","volume":"9","author":"Liu","year":"2020","journal-title":"Elife"},{"key":"R26-20240807","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jbi.2017.11.015","article-title":"Flexible, cluster-based analysis of the electronic medical record of sepsis with composite mixture models.","volume":"78","author":"Mayhew","year":"2018","journal-title":"J Biomed Inform"},{"key":"R27-20240807","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1016\/j.ajem.2016.08.031","article-title":"Presenting hemodynamic phenotypes in ED patients with confirmed sepsis.","volume":"34","author":"Nowak","year":"2016","journal-title":"Am J Emerg Med"},{"key":"R28-20240807","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1097\/CCM.0000000000003084","article-title":"Unsupervised analysis of transcriptomics in bacterial sepsis across multiple datasets reveals three robust clusters.","volume":"46","author":"Sweeney","year":"2018","journal-title":"Crit Care Med"},{"key":"R29-20240807","doi-asserted-by":"crossref","first-page":"103081","DOI":"10.1016\/j.ebiom.2020.103081","article-title":"Deep learning-based clustering robustly identified two classes of sepsis with both prognostic and predictive values.","volume":"62","author":"Zhang","year":"2020","journal-title":"EBioMedicine"},{"key":"R30-20240807","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1186\/s13054-020-02950-2","article-title":"Mortality in sepsis and septic shock in Europe, North America and Australia between 2009 and 2019-results from a systematic review and meta-analysis.","volume":"24","author":"Bauer","year":"2020","journal-title":"Crit Care"},{"key":"R31-20240807","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1056\/NEJMoa010307","article-title":"Early goal-directed therapy in the treatment of severe sepsis and septic shock.","volume":"345","author":"Rivers","year":"2001","journal-title":"N Engl J Med"},{"key":"R33-20240807","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1001\/jama.2021.13304","article-title":"Updated guidance on the reporting of race and ethnicity in medical and science journals.","volume":"326","author":"Flanagin","year":"2021","journal-title":"JAMA"}],"container-title":["Critical Care Explorations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CCE.0000000000000672","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T14:38:46Z","timestamp":1723041526000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CCE.0000000000000672"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,30]]},"references-count":31,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/cce.0000000000000672","relation":{},"ISSN":["2639-8028"],"issn-type":[{"value":"2639-8028","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,30]]}}}